Sexual & Reproductive Health drugs

37 results

  • addyi

    (flibanserin)
    Sprout Pharmaceuticals, Inc.
    ADDYI is indicated for treating premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) that causes significant distress and is not linked to medical/psychiatric conditions, relationship issues, or medication effects. It is not approved for postmenopausal women, men, or to enhance sexual performance.

  • annovera

    (segesterone acetate and ethinyl estradiol)
    TherapeuticsMD, Inc.
    ANNOVERA is indicated for females of reproductive potential to prevent pregnancy. It is not adequately studied in females with a BMI greater than 29 kg/m².

  • avastin

    (bevacizumab)
    Genentech, Inc.
    Avastin is indicated for the treatment of various cancers, including metastatic colorectal cancer, non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, persistent or recurrent cervical cancer, and advanced epithelial ovarian or peritoneal cancers, often in combination with other chemotherapy agents.

  • aveed

    (testosterone undecanoate)
    ENDO USA, Inc.
    AVEED is indicated for testosterone replacement therapy in adult males with conditions related to testosterone deficiency, including primary and hypogonadotropic hypogonadism. It should only be used when benefits outweigh risks, with safety and efficacy not established for age-related hypogonadism or in males under 18.

  • bijuva

    (estradiol and progesterone)
    Mayne Pharma LLC
    The drug is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause.

  • edex

    (alprostadil)
    ENDO USA, Inc.
    Edex® is indicated for treating erectile dysfunction stemming from various causes, including neurogenic, vasculogenic, psychogenic, or mixed origins.

  • estrogel

    (estradiol)
    ASCEND Therapeutics US, LLC
    This drug is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar and vaginal atrophy associated with menopause. For vulvar and vaginal atrophy, topical vaginal products should be considered first if symptoms are the sole concern.

  • evamist

    (Estradiol)
    Padagis US LLC
    This drug is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause.

  • gardasil 9

    (Human Papillomavirus 9-valent Vaccine, Recombinant)
    Merck Sharp & Dohme LLC
    GARDASIL® 9 is a vaccine for girls and women aged 9-45 and boys and men aged 9-45, preventing certain cancers and genital warts caused by specific HPV types. It targets cervical, vulvar, vaginal, anal, and oropharyngeal cancers, as well as precancerous lesions related to these HPV strains.

  • imvexxy

    (estradiol)
    Mayne Pharma LLC
    This drug is indicated for the treatment of moderate to severe dyspareunia, which is a symptom of vulvar and vaginal atrophy resulting from menopause.